173
Views
12
CrossRef citations to date
0
Altmetric
Original

Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia

, , , , , , , , & show all
Pages 1200-1207 | Received 31 Oct 2006, Accepted 13 Mar 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stephan R. Bohl, Anna Dolnik, Thomas Jensen, Katharina M. Lang, Björn Hackanson, Verena I. Gaidzik, Peter Paschka, Steen Knudsen, Konstanze Döhner, Hartmut Döhner, Rainer Claus, Michael Lübbert & Lars Bullinger. (2017) Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes. Leukemia & Lymphoma 58:9, pages 2264-2267.
Read now

Articles from other publishers (11)

Edward V. Prochownik & Huabo Wang. (2022) Normal and Neoplastic Growth Suppression by the Extended Myc Network. Cells 11:4, pages 747.
Crossref
Judit Liaño-Pons, Marie Arsenian-Henriksson & Javier León. (2021) The Multiple Faces of MNT and Its Role as a MYC Modulator. Cancers 13:18, pages 4682.
Crossref
Farhan Basit, Maria Andersson & Anne Hultquist. (2018) The Myc/Max/Mxd Network Is a Target of Mutated Flt3 Signaling in Hematopoietic Stem Cells in Flt3-ITD-Induced Myeloproliferative Disease. Stem Cells International 2018, pages 1-9.
Crossref
Isha Kapoor, Jitendra Kanaujiya, Yogesh Kumar, Jagadeshwar Reddy Thota, Madan L.B. Bhatt, Naibedya Chattopadhyay, Sabyasachi Sanyal & Arun Kumar Trivedi. (2015) Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation. Oncotarget 7:7, pages 7640-7656.
Crossref
Daniel Diolaiti, Lisa McFerrin, Patrick A. Carroll & Robert N. Eisenman. (2015) Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849:5, pages 484-500.
Crossref
David A. Erichsen, Michael B. Armstrong & Daniel S. Wechsler. (2015) Mxi1 and Mxi1-0 Antagonize N-Myc Function and Independently Mediate Apoptosis in Neuroblastoma. Translational Oncology 8:1, pages 65-74.
Crossref
Michael B. Armstrong, Rajen J. Mody, D. Christian Ellis, Adam B. Hill, David A. Erichsen & Daniel S. Wechsler. (2013) N-Myc Differentially Regulates Expression of MXI1 Isoforms in Neuroblastoma. Neoplasia 15:12, pages 1363-1370.
Crossref
Valentina Manfè, Edyta Biskup, Ayalah Willumsgaard, Anne Guldhammer Skov, Dario Palmieri, Pierluigi Gasparini, Alessandro Laganá, Anders Woetmann, Niels Ødum, Carlo Maria Croce & Robert Gniadecki. (2013) cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas. PLoS ONE 8:3, pages e59390.
Crossref
Bernhard Lüscher. (2012) MAD1 and its life as a MYC antagonist: An update. European Journal of Cell Biology 91:6-7, pages 506-514.
Crossref
Chao-Kai Chou, Dung-Fang Lee, Hui-Lung Sun, Long-Yuan Li, Chun-Yi Lin, Wei-Chien Huang, Jung-Mao Hsu, Hsu-Ping Kuo, Hirohito Yamaguchi, Ying-Nai Wang, Mo Liu, Hsin-Yi Wu, Pao-Chi Liao, Chia-Jui Yen & Mien-Chie Hung. (2009) The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription. Molecular Carcinogenesis 48:11, pages 1048-1058.
Crossref
Adela Urisarri-Ruiz de Cortázar, Marta Gil Calvo, Manuel Vázquez Donsión, Gema Ariceta Iraola & Jose Miguel Couselo Sánchez. (2009) Renal dysplasia/hypoplasia, Williams Syndrome phenotype and non-Hodgkin lymphoma in the same patient: only a coincidence?. Pediatric Nephrology 24:5, pages 1081-1084.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.